XWELL, Inc. (XWEL)
NASDAQ: XWEL · IEX Real-Time Price · USD
1.740
-0.050 (-2.79%)
May 17, 2024, 4:00 PM EDT - Market closed

XWELL Revenue

XWELL had revenue of $31.77M in the twelve months ending March 31, 2024, down -18.44% year-over-year. Revenue in the quarter ending March 31, 2024 was $8.73M with 23.55% year-over-year growth. In the year 2023, XWELL had annual revenue of $30.11M, a decrease of -46.18%.

Revenue (ttm)
$31.77M
Revenue Growth
-18.44%
P/S Ratio
0.24
Revenue / Employee
$119,444
Employees
266
Market Cap
7.53M USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202330.11M-25.83M-46.18%
Dec 31, 202255.94M-17.79M-24.13%
Dec 31, 202173.73M65.34M779.30%
Dec 31, 20208.39M-40.13M-82.72%
Dec 31, 201948.52M-1.58M-3.15%
Dec 31, 201850.09M1.27M2.60%
Dec 31, 201748.82M36.84M307.33%
Dec 31, 201611.99M-10.70M-47.17%
Dec 31, 201522.69M21.26M1,492.07%
Dec 31, 20141.43M325.00K29.55%
Dec 31, 20131.10M1.00M1,000.00%
Dec 31, 2012100.00K-618.00K-86.07%
Dec 31, 2011718.00K507.00K240.28%
Dec 31, 2010211.00K191.00K955.00%
Dec 31, 200920.00K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Telesis Bio 24.63M
Intelligent Bio Solutions 3.21M
Trevena 3.14M
TFF Pharmaceuticals 885.72K
Vaccinex 124.00K
Oragenics 20.63K
Heart Test Laboratories 18.60K
Revenue Rankings